StockData
Tenon Medical, Inc. logo

Tenon Medical, Inc. (TNON) shareholders

TNONNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TNONW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/30
$1.25−0.08 (-6.37%)

Close on Nov 17, 2026Market cap $833.81KP/E –Yield –

Ownership

Who owns Tenon Medical's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
9 buys · 9 sales
Net sold $105.45K

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
SiVantage Inc.986,52812.50%13D (active)Aug 1, 2025
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
54,5549.99%13G (passive)Jun 30, 2026
TMD Wealth Management LLC––13G (passive) amendmentJul 1, 2024

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Steven M. FosterCEO and President, Director262,962Aug 4, 2026
Richard GinnChief Technology Officer, Director167,357Aug 4, 2026
Thomas Henry Batton JrChief Revenue Officer–Oct 9, 2026
Kevin WilliamsonChief Financial Officer2,580Sep 10, 2026
Nathaniel A. GraweyChief Commercial Officer482,865May 5, 2026
Wyatt D. GeistChief Innovation Officer644,735May 5, 2026
Kristine M. JacquesDirector20,876Aug 4, 2026
Richard FerrariDirector293,375Aug 4, 2026
Stephen HochschulerDirector38,395Aug 4, 2026
Robert K. WeigleDirector18,284Aug 4, 2026
Ivan HowardDirector85,112Aug 4, 2026
Financial Lp Hrt10% owner15,839Sep 11, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Financial Lp Hrt
10% owner
Sep 10, 2026Buy+31,227$2.92$91.18K15,839
Financial Lp Hrt
10% owner
Sep 10, 2026Buy+28,267$4.02$113.63K15,839
Financial Lp Hrt
10% owner
Sep 10, 2026Buy+8,431$4.92$41.48K15,839
Financial Lp Hrt
10% owner
Sep 10, 2026Sale−65,582$5.56$364.64K15,839
Financial Lp Hrt
10% owner
Sep 9, 2026Sale−9,948$4.27$42.48K18,182
Financial Lp Hrt
10% owner
Sep 9, 2026Buy+39,508$3.40$134.33K18,182
Financial Lp Hrt
10% owner
Sep 9, 2026Sale−50,395$2.61$131.53K18,182
Kevin Williamson
Chief Financial Officer
Sep 9, 2026Tax withholding−11$3.45$382,580
Financial Lp Hrt
10% owner
Sep 8, 2026Buy+707$3.34$2.36K2,653
Kevin Williamson
Chief Financial Officer
Sep 8, 2026Option exercise+30––2,591
Financial Lp Hrt
10% owner
Sep 4, 2026Sale−1,506$3.70$5.57K1,946
Financial Lp Hrt
10% owner
Sep 3, 2026Buy+1,658$3.98$6.60K3,452
Financial Lp Hrt
10% owner
Sep 2, 2026Sale−450$4.53$2.04K1,794
Financial Lp Hrt
10% owner
Sep 1, 2026Buy+1,790$4.57$8.18K2,244
Financial Lp Hrt
10% owner
Aug 31, 2026Sale−1,276$4.66$5.95K454
Financial Lp Hrt
10% owner
Aug 28, 2026Sale−2,091$7.90$16.52K1,730
Financial Lp Hrt
10% owner
Aug 28, 2026Sale−4,932$7.07$34.87K1,730
Financial Lp Hrt
10% owner
Aug 28, 2026Buy+5,981$6.35$37.98K1,730
Financial Lp Hrt
10% owner
Aug 28, 2026Buy+12,376$5.21$64.48K1,730
Financial Lp Hrt
10% owner
Aug 27, 2026Sale−419$4.96$2.08K9,604
Richard Ginn
Chief Technology Officer, Director
Aug 3, 2026Tax withholding−44,809$0.20$8.96K167,357
Steven M. Foster
CEO and President, Director
Aug 3, 2026Tax withholding−41,788$0.20$8.36K262,962
Kevin Williamson
Chief Financial Officer
Aug 3, 2026Tax withholding−12,978$0.20$2.60K89,602
Richard Ferrari
Director
Jul 31, 2026Option exercise+64,479––135,243
Kristine M. Jacques
Director
Jul 31, 2026Option exercise+10,147––20,876
Richard Ginn
Chief Technology Officer, Director
Jul 31, 2026Option exercise+126,577––212,166
Steven M. Foster
CEO and President, Director
Jul 31, 2026Option exercise+140,936––304,750
Robert K. Weigle
Director
Jul 31, 2026Option exercise+10,732––18,284
Kevin Williamson
Chief Financial Officer
Jul 31, 2026Option exercise+58,987––102,580
Stephen Hochschuler
Director
Jul 31, 2026Option exercise+10,732––18,670
Ivan Howard
Director
Jul 31, 2026Option exercise+10,732––19,194
Wyatt D. Geist
Chief Innovation Officer
May 1, 2026Award+136,401––487,166
Nathaniel A. Grawey
Chief Commercial Officer
May 1, 2026Award+68,201––243,584
Kevin Williamson
Chief Financial Officer
Mar 3, 2026Option exercise+1,041––43,593
Kevin Williamson
Chief Financial Officer, Director
Jan 5, 2026Tax withholding−18,518$0.93$17.22K42,552
Richard Ginn
Chief Technology Officer, Director
Jan 5, 2026Tax withholding−47,426$0.93$44.11K85,589
Robert K. Weigle
Director
Jan 5, 2026Tax withholding−3,413$0.93$3.17K7,552
Stephen Hochschuler
Director
Jan 5, 2026Tax withholding−3,327$0.93$3.09K7,938
Ivan Howard
Director
Jan 5, 2026Tax withholding−3,327$0.93$3.09K8,462
Kevin Williamson
Chief Financial Officer, Director
Jan 1, 2026Option exercise+58,987––61,070
Steven M. Foster
CEO and President, Director
Jan 1, 2026Option exercise+140,936––163,814
Richard Ginn
Chief Technology Officer, Director
Jan 1, 2026Option exercise+126,577––133,015
Robert K. Weigle
Director
Jan 1, 2026Option exercise+10,732––10,965
Stephen Hochschuler
Director
Jan 1, 2026Option exercise+10,732––11,265
Kristine M. Jacques
Director
Jan 1, 2026Option exercise+583––10,729
Kristine M. Jacques
Director
Jan 1, 2026Option exercise+10,146––10,146
Ivan Howard
Director
Jan 1, 2026Option exercise+10,732––11,789
Richard Ferrari
Director
Jan 1, 2026Option exercise+64,478––70,764
Steven M. Foster
CEO and President, Director
Nov 14, 2025Buy+19,455––22,878
Nathaniel A. Grawey
Chief Commercial Officer
Nov 14, 2025Buy+101,167––239,281
Wyatt D. Geist
Chief Innovation Officer
Nov 14, 2025Buy+19,455––157,569
Kevin Williamson
Chief Financial Officer, Director
Sep 3, 2025Option exercise+2,083––2,083
Ivan Howard
Director
May 22, 2025Option exercise+78––1,057
Robert K. Weigle
Director
May 22, 2025Option exercise+78––233
Ivan Howard
Director
May 22, 2024Option exercise+78––979
Robert K. Weigle
Director
May 22, 2024Option exercise+78––155
Steven M. Foster
CEO and President, Director
Nov 27, 2023Tax withholding−901$2.00$1.80K8,730
Richard Ginn
Chief Technology Officer, Director
Nov 27, 2023Tax withholding−2,302$2.00$4.60K70,963
Dick Steven M. Van
Chief Financial Officer
Nov 22, 2023Conversion+1,522$2.02$3.07K11,565
Steven M. Foster
CEO and President, Director
Nov 22, 2023Conversion+3,624$2.02$7.32K9,631

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+82.8%
From 0M shares
Short volume, 20 days
47.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Tenon Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 692,189 shares on Sep 14, 2026 over the last 90 days.

See a number that looks wrong?